Table 3.
Comparison of patient characteristics by allograft type
| Allograft type |
p value |
|||||
|---|---|---|---|---|---|---|
| Heart (18) | Kidney (11) | Liver (21) | Heart vs. kidney | Heart vs. liver | Kidney vs. liver | |
| Immunosuppression | ||||||
| Tacrolimus | 88.9% | 90.9% | 85.7% | – | – | – |
| MMF | 72.2% | 72.7% | 33.3% | – | – | – |
| Cyclosporine | 5.6% | 9.1% | 4.8% | – | – | – |
| Azathioprine | 5.6% | 0.0% | 0.0% | – | – | – |
| Cyclophosphamide | 0.0% | 0.0% | 0.0% | – | – | – |
| mTOR inhibitor | 5.6% | 0.0% | 9.5% | – | – | – |
| Corticosteroid | 33.3% | 18.2% | 9.5% | – | – | – |
| Methylprednisolone | 0.0% | 9.1% | 0.0% | – | – | – |
| Other | 16.7% | 0.0% | 4.8% | – | – | – |
| Induction medication | ||||||
| ATG (thymoglobulin) | 33% | 55% | 10% | – | – | – |
| Basiliximab | 11% | 9% | 5% | – | – | – |
| Methylprednisolone | 22% | 36% | 52% | – | – | – |
| IVIg | 17% | 0% | 0% | – | – | – |
| None | 17% | 0% | 33% | – | – | – |
| Age at collection (days) | 3,962 ± 2,345 | 3,819 ± 2,508 | 2,928 ± 2,033 | 0.985 | 0.335 | 0.543 |
| Time post-transplant (days) | 693 ± 499 | 551 ± 315 | 614 ± 487 | 0.703 | 0.857 | 0.928 |